Cancer Therapeutics CRC (CTx) is dedicated to Finding Cures for Cancer. CTx is an oncology focused small molecule drug discovery and early development biotechnology group. We were established under the Australian government’s Cooperative Research Centre (CRC) initiative. Our unique collaboration model leverages the capabilities and expertise of its Industry Participants with those of a number of Australia’s pre-eminent Medical Research Institutes and Universities. CTx has successfully discovered, developed and commercialised small molecule cancer drugs to the global pharmaceutical market.
View Top Employees from Cancer Therapeutics CRC (CTx)| Website | http://www.cancercrc.com |
| Revenue | $13 million |
| Employees | 9 (2 on RocketReach) |
| Founded | 2007 |
| Address | 305 Grattan St, Melbourne, Victoria 3000, AU |
| Phone | +61 3 6388 7830 |
| Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
| Industry | Business Services General, Biotechnology, Cancer Research, Business Services, Science and Engineering, Commercialisation, Collaborative Research Centre |
| Web Rank | 17 Million |
| Keywords | Cancer Therapeutics Crc, Lisa Dube Crc Cancer, Crc Cancer Therapeutics Pipeline, Dr Warick Tong |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Cancer Therapeutics CRC (CTx) employee's phone or email?
Cancer Therapeutics CRC (CTx) Questions
The Cancer Therapeutics CRC (CTx) annual revenue was $13 million in 2024.
Kurt Lackovic is the CEO of Cancer Therapeutics CRC (CTx).
2 people are employed at Cancer Therapeutics CRC (CTx).
Cancer Therapeutics CRC (CTx) is based in Melbourne, Victoria.
The NAICS codes for Cancer Therapeutics CRC (CTx) are [541713, 541, 5417, 54, 54171].
The SIC codes for Cancer Therapeutics CRC (CTx) are [873, 87].
Top Cancer Therapeutics CRC (CTx) Employees
